Big Pharma Increasingly Pursues Long-Term Deal Investment

doi:10.3833/pdcmx.v2012i1.1670

PharmaDeals Corp-METRx, Vol 2012, No 1 (2012)

Big Pharma Increasingly Pursues Long-Term Deal Investment

Heather Cartwright

Abstract

Roche, Pfizer and GlaxoSmithKline (GSK) have begun 2012 as they ended 2011 as the top 3 companies, respectively, in the PharmaDeals Corp-METRx Deal Activity League Table.